Detalles de la búsqueda
1.
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom.
Br J Cancer
; 130(12): 1916-1920, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658782
2.
High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.
Cancer
; 125(16): 2772-2781, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31154673
3.
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment.
BMC Cancer
; 18(1): 636, 2018 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29866066
4.
Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer.
Eur Radiol
; 27(11): 4602-4611, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28523352
5.
Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer?
Breast Cancer Res Treat
; 143(1): 153-7, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24305976
6.
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
JAMA
; 307(4): 382-90, 2012 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-22274685
7.
Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification.
Clin Cancer Res
; 28(16): 3546-3556, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35696721
8.
BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.
Gynecol Oncol
; 123(3): 492-8, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21920589
9.
Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.
Eur J Cancer
; 76: 52-59, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28273485
10.
An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients.
Ecancermedicalscience
; 10: 608, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26913066
11.
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer.
Clin Cancer Res
; 21(3): 652-7, 2015 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25398451
12.
Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
J Immunol Methods
; 378(1-2): 20-32, 2012 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22361111
13.
Increased incidence of visceral metastases in scottish patients with BRCA1/2-defective ovarian cancer: an extension of the ovarian BRCAness phenotype.
J Clin Oncol
; 28(15): 2505-11, 2010 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20406939
Resultados
1 -
13
de 13
1
Próxima >
>>